These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Lassa Virus Cell Entry via Dystroglycan Involves an Unusual Pathway of Macropinocytosis. Oppliger J; Torriani G; Herrador A; Kunz S J Virol; 2016 Jul; 90(14):6412-6429. PubMed ID: 27147735 [TBL] [Abstract][Full Text] [Related]
5. Lamp1 Increases the Efficiency of Lassa Virus Infection by Promoting Fusion in Less Acidic Endosomal Compartments. Hulseberg CE; Fénéant L; Szymańska KM; White JM mBio; 2018 Jan; 9(1):. PubMed ID: 29295909 [TBL] [Abstract][Full Text] [Related]
6. Screening and Identification of Lassa Virus Entry Inhibitors from an FDA-Approved Drug Library. Wang P; Liu Y; Zhang G; Wang S; Guo J; Cao J; Jia X; Zhang L; Xiao G; Wang W J Virol; 2018 Aug; 92(16):. PubMed ID: 29899092 [No Abstract] [Full Text] [Related]
7. Identification of a clinical compound losmapimod that blocks Lassa virus entry. Zhang X; Yan F; Tang K; Chen Q; Guo J; Zhu W; He S; Banadyga L; Qiu X; Guo Y Antiviral Res; 2019 Jul; 167():68-77. PubMed ID: 30953674 [TBL] [Abstract][Full Text] [Related]
8. The antifungal isavuconazole inhibits the entry of lassa virus by targeting the stable signal peptide-GP2 subunit interface of lassa virus glycoprotein. Zhang X; Tang K; Guo Y Antiviral Res; 2020 Feb; 174():104701. PubMed ID: 31877348 [TBL] [Abstract][Full Text] [Related]
12. Small-Molecule Fusion Inhibitors Bind the pH-Sensing Stable Signal Peptide-GP2 Subunit Interface of the Lassa Virus Envelope Glycoprotein. Shankar S; Whitby LR; Casquilho-Gray HE; York J; Boger DL; Nunberg JH J Virol; 2016 Aug; 90(15):6799-807. PubMed ID: 27194767 [TBL] [Abstract][Full Text] [Related]
13. Novel Small Molecule Entry Inhibitors of Ebola Virus. Basu A; Mills DM; Mitchell D; Ndungo E; Williams JD; Herbert AS; Dye JM; Moir DT; Chandran K; Patterson JL; Rong L; Bowlin TL J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S425-34. PubMed ID: 26206510 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists. Cheng H; Lear-Rooney CM; Johansen L; Varhegyi E; Chen ZW; Olinger GG; Rong L J Virol; 2015 Oct; 89(19):9932-8. PubMed ID: 26202243 [TBL] [Abstract][Full Text] [Related]
15. A novel Odongo L; Habtegebrael BH; Kiessling V; White JM; Tamm LK Microbiol Spectr; 2023 Sep; 11(5):e0190823. PubMed ID: 37728342 [TBL] [Abstract][Full Text] [Related]
16. Screening and identification of Lassa virus endonuclease-targeting inhibitors from a fragment-based drug discovery library. Lan X; Zhang Y; Jia X; Dong S; Liu Y; Zhang M; Guo J; Cao J; Guo Y; Xiao G; Wang W Antiviral Res; 2022 Jan; 197():105230. PubMed ID: 34965446 [TBL] [Abstract][Full Text] [Related]
18. Characterization of the inhibitory effect of an extract of Prunella vulgaris on Ebola virus glycoprotein (GP)-mediated virus entry and infection. Zhang X; Ao Z; Bello A; Ran X; Liu S; Wigle J; Kobinger G; Yao X Antiviral Res; 2016 Mar; 127():20-31. PubMed ID: 26778707 [TBL] [Abstract][Full Text] [Related]
19. Comprehensive Interactome Analysis Reveals that STT3B Is Required for N-Glycosylation of Lassa Virus Glycoprotein. Zhu S; Wan W; Zhang Y; Shang W; Pan X; Zhang LK; Xiao G J Virol; 2019 Dec; 93(23):. PubMed ID: 31511384 [TBL] [Abstract][Full Text] [Related]